Alembic Pharmaceuticals Limited (NSE:APLLTD)
India · Delayed Price · Currency is INR 790.00
+2.95 (0.37%)
May 11, 2026, 3:29 PM IST
Alembic Pharmaceuticals Market Cap
Alembic Pharmaceuticals has a market cap or net worth of 155.13 billion as of May 11, 2026. Its market cap has decreased by -7.14% in one year.
Market Cap
155.13B
Enterprise Value
168.55B
Revenue
72.67B
Ranking
n/a
PE Ratio
24.61
Stock Price
790.00
Market Cap Chart
Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 155.13B, an increase of 1,623.33%. That is a compound annual growth rate of 21.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 154.71B | -6.98% |
| Dec 31, 2025 | 166.32B | -20.64% |
| Dec 31, 2024 | 209.59B | 40.41% |
| Dec 29, 2023 | 149.27B | 32.55% |
| Dec 30, 2022 | 112.61B | -28.56% |
| Dec 31, 2021 | 157.62B | -22.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gland Pharma | 313.76B |
| Emcure Pharmaceuticals | 311.50B |
| Wockhardt | 261.04B |
| Piramal Pharma | 238.81B |
| NATCO Pharma | 210.40B |
| Eris Lifesciences | 192.03B |
| Cohance Lifesciences | 186.77B |
| Alivus Life Sciences | 137.62B |